Chile vs Singapore: Cause of death, by non-communicable diseases, ages 60+, male
Chile
74.4%
in 2021
Singapore
74.0%
in 2021
Chile rank
69th
Singapore rank
72nd
Cause of death, by non-communicable diseases, ages 60+, male over time
- Chile
- Singapore
How they compare
Chile currently reports 74.4% against 74.0% in Singapore, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Chile ahead.
Chile ranks 69th and Singapore ranks 72nd of 185 countries.
Across the 3 decades both report, Chile averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Chile | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.0% | 81.9% | 4.1% | Chile |
| 2010s | 88.3% | 74.8% | 13.4% | Chile |
| 2020s | 74.2% | 74.8% | 0.6% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Chile or Singapore?
- Chile, at 74.4% against 74.0% in Singapore as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Chile and Singapore?
- 0.4%, with Chile ahead.
- How many years of comparable data are there for Chile and Singapore?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and Singapore rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Chile ranks 69th and Singapore ranks 72nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.